Prognostic implications of epicardial fat volume quantification in acute pericarditis

European Journal of Clinical Investigation

Volumn 47, Issue 2, 2017, Pages 129-136

  Lazaros, George ^a   Antonopoulos, Alexios S ^a,b   Oikonomou, Evangelos K ^a,b   Vasileiou, Panagiotis ^a   Oikonomou, Evangelos ^a   Stroumpouli, Evangelia ^a   Karavidas, Apostolos ^a   Antoniades, Charalambos ^b   Tousoulis, Dimitris ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acute pericarditis; adipose tissue; computer tomography imaging; epicardial fat

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIAC IMAGING; CARDIAC PATIENT; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OUTCOME; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPICARDIAL FAT; EPICARDIAL FAT VOLUME; FEMALE; FOLLOW UP; HUMAN; LIMIT OF QUANTITATION; MALE; PERICARDIAL EFFUSION; PERICARDITIS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; THORAX PAIN; TREATMENT RESPONSE; ACUTE DISEASE; ADIPOSE TISSUE; AFTERCARE; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ADIPOSE TISSUE; AFTERCARE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ATRIAL FIBRILLATION; CHEST PAIN; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PERICARDITIS; RECURRENCE; TREATMENT OUTCOME;

EID: 85007422404     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12711     Document Type: Article

References (27)

1. Imazio M, Cecchi E, Demichelis B, Chinaglia A, Ierna S, Demarie D et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart 2008;94:498–501.
2. Lazaros G, Imazio M, Tousoulis D. Letter by Lazaros et al. Regarding Article, “Clinical Profile and Influences on Outcomes in Patients Hospitalized for Acute Pericarditis”. Circulation 2015;132:e127.
3. LeWinter MM. Clinical practice. Acute pericarditis. N EngL J Med 2014;371:2410–6.
4. Imazio M, Brucato A, Maestroni S, Cumetti D, Belli R, Trinchero R et al. Risk of constrictive pericarditis after acute pericarditis. Circulation 2011;124:1270–5.
5. Imazio M, Brucato A, Maestroni S, Cumetti D, Dominelli A, Natale G et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation 2011;123:1092–7.
6. Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y. Controversial issues in the management of pericardial diseases. Circulation 2010;121:916–28.
7. Antonopoulos AS, Margaritis M, Verheule S, Recalde A, Sanna F, Herdman L et al. Mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-gamma/Adiponectin Signalling. Circ Res 2016;118:842–55.
8. Nakanishi R, Rajani R, Cheng VY, Gransar H, Nakazato R, Shmilovich H et al. Increase in epicardial fat volume is associated with greater coronary artery calcification progression in subjects at intermediate risk by coronary calcium score: a serial study using non-contrast cardiac CT. Atherosclerosis 2011;218:363–8.
9. Spearman JV, Renker M, Schoepf UJ, Krazinski AW, Herbert TL, De Cecco CN et al. Prognostic value of epicardial fat volume measurements by computed tomography: a systematic review of the literature. Eur Radiol 2015;25:3372–81.
10. Do GW, Ku BS, Park CS, Kim SJ, Shin ES, Choi SH et al. A case of constrictive pericarditis associated with huge epicardial fat volume. Korean Circ J 2009;39:116–20.
11. Maisch B, Seferovic PM, Ristic AD, Erbel R, Rienmuller R, Adler Y et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 2004;25:587–610.
12. Imazio M, Cecchi E, Demichelis B, Ierna S, Demarie D, Ghisio A et al. Indicators of poor prognosis of acute pericarditis. Circulation 2007;115:2739–44.
13. Imazio M, Demichelis B, Parrini I, Cecchi E, Demarie D, Ghisio A et al. Management, risk factors, and outcomes in recurrent pericarditis. Am J Cardiol 2005;96:736–9.
14. Lazaros G, Vlachopoulos C, Stefanadis C. Idiopathic recurrent pericarditis: searching for Ariadne's thread. Hellenic J Cardiol 2009;50:345–51.
15. Cheng VY, Dey D, Tamarappoo B, Nakazato R, Gransar H, Miranda-Peats R et al. Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. JACC Cardiovasc Imaging 2010;3:352–60.
16. Imazio M, Adler Y. Management of pericardial effusion. Eur Heart J 2013;34:1186–97.
17. Antonopoulos AS, Margaritis M, Coutinho P, Digby J, Patel R, Psarros C et al. Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol 2014;34:2151–9.
18. Antonopoulos AS, Margaritis M, Coutinho P, Shirodaria C, Psarros C, Herdman L et al. Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 2015;64:2207–19.
19. Margaritis M, Antonopoulos AS, Digby J, Lee R, Reilly S, Coutinho P et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 2013;127:2209–21.
20. Yavuz S, Kasap M, Akpinar G, Ozbudak E, Ural D, Berki T. Analysis of pericardial effusion from idiopathic pericarditis patients by two-dimensional gel electrophoresis. BioMed Res Int 2014;2014:942718.
21. Imazio M, Lazaros G, Picardi E, Vasileiou P, Orlando F, Carraro M et al. Incidence and prognostic significance of new onset atrial fibrillation/flutter in acute pericarditis. Heart 2015;101:1463–7.
22. Wong CX, Ganesan AN, Selvanayagam JB. Epicardial fat and atrial fibrillation: current evidence, potential mechanisms, clinical implications, and future directions. Eur Heart J 2016;doi: 10.1093/eurheartj/ehw045.
23. Zhu W, Zhang H, Guo L, Hong K. Relationship between epicardial adipose tissue volume and atrial fibrillation: a systematic review and meta-analysis. Herz 2016;41:421–7.
24. Imazio M, Belli R, Brucato A, Cemin R, Ferrua S, Beqaraj F et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 2014;383:2232–7.
25. Vasileiou P, Tsioufis C, Lazaros G, Hadziyannis E, Kasiakogias A, Stefanadis C et al. Interleukin-8 as a predictor of acute idiopathic pericarditis recurrences. A pilot study. Int J Cardiol 2014;172:e463–4.
26. Markel G, Imazio M, Koren-Morag N, Galore-Haskel G, Schachter J, Besser M et al. CEACAM1 and MICA as novel serum biomarkers in patients with acute and recurrent pericarditis. Oncotarget 2016;7:17885–95.
27. Antonopoulos AS, Oikonomou EK, Antoniades C, Tousoulis D. From the BMI paradox to the obesity paradox: the obesity-mortality association in coronary heart disease. Obes Rev 2016;17:989–1000.